Skip to content

Jacob M Hooker

3 papers in the library · 108 citations · publishing 2008-2023

Papers

Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans.

NeuroImage July 1, 2008 Jacob M Hooker, Youwen Xu, Wynne Schiffer et al. 106 citations

Salvinorin A, the psychoactive component of the mint plant Salvia divinorum, is a uniquely potent agonist at kappa-opioid receptors. Positron emission tomography (PET) studies in 6 adult female baboons showed extremely rapid brain uptake, reaching a peak of 3.3% of the total administered dose within 40 seconds and clearing with a half-life of 8 minutes. The compound distributed throughout the brain, with highest concentration in the cerebellum and notable concentration in the visual cortex, which may account for visual hallucinations when smoked. Naloxone did not reduce overall concentration or alter regional distribution. The rapid brain kinetics match the brief time-course of visual hallucinations, and effects may occur at less than 10 micrograms in the human brain, emphasizing its remarkable potency.

Light Shining within the "Dark" Classics: A Perspective on Entheogenic Compounds.

ACS chemical neuroscience May 17, 2023 Khalyd J Clay, Ava E Axelrod, Christina M MacLaughlin et al. 2 citations

Several naturally occurring molecules, including entheogens—plant-derived compounds used by Indigenous groups for religious or spiritual purposes—show unique potential for treating psychiatric illnesses and are being pursued in therapeutic development. This viewpoint argues that labeling such compounds as "DARK" in ACS Chemical Neuroscience issues perpetuates harmful stigmas. The authors propose reframing these substances in the light and beauty of their cultural and historical contexts, urging a shift in language surrounding entheogens and psychedelics more broadly.

Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology December 1, 2015 Michael S Placzek, Genevieve C Van de Bittner, Hsiao-Ying Wey et al.

Kappa opioid receptor (KOR) binding availability in the brain was measured in living rats using positron emission tomography (PET) after administration of the KOR agonist salvinorin A. At lower doses, salvinorin A briefly competed for receptor binding but had no lasting effect. At a dose of 0.60 mg/kg, however, it induced a sustained decrease in KOR binding of 40–49% that persisted for up to 2.5 hours after the drug had left the brain, suggesting an adaptive response by the receptor not previously observed in vivo with PET.